MX2007005172A - Terapia adjunta para la depresion. - Google Patents

Terapia adjunta para la depresion.

Info

Publication number
MX2007005172A
MX2007005172A MX2007005172A MX2007005172A MX2007005172A MX 2007005172 A MX2007005172 A MX 2007005172A MX 2007005172 A MX2007005172 A MX 2007005172A MX 2007005172 A MX2007005172 A MX 2007005172A MX 2007005172 A MX2007005172 A MX 2007005172A
Authority
MX
Mexico
Prior art keywords
manufacture
methods
shaving razors
blade subassemblies
subassemblies therefor
Prior art date
Application number
MX2007005172A
Other languages
English (en)
Inventor
Jonathan Sporn
Original Assignee
Sk Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Corp filed Critical Sk Corp
Publication of MX2007005172A publication Critical patent/MX2007005172A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dry Shavers And Clippers (AREA)

Abstract

Esta invencion se refiere a un metodo de tratamiento de depresion en un sujeto, que comprende la etapa de la administracion de una cantidad terapeuticamente efectiva de un antidepresivo convencional y, ademas, la administracion al sujeto de una cantidad terapeuticamente efectiva de un compuesto de la formula (I) (ver formula (I)): o su sal o ester farmaceuticamente aceptable en donde Rx es un miembro seleccionado del grupo que consiste de hidrogeno, alquilo inferior de 1 a 8 atomos de carbono, halogeno seleccionado del F, Cl, Br y I, alcoxi que contiene de 1 a 3 atomos de carbono, nitro, hidroxi, trifluorometilo, y tioalcoxi que contiene de 1 a 3 atomos de carbono; x es un numero entero de 1 a 3, con la condicion de que R puede ser el mismo o diferente cuando x es 2 o 3; R1 y R2 pueden ser los mismos o diferentes uno de otro y se seleccionan independientemente del grupo que consiste de hidrogeno, alquilo inferior de 1 a 8 atomos de carbono, arilo, arilalquilo, cicloalquilo de 3 a 7 atomos de carbono; R1 y R2 se pueden unir para formar un heterociclo de 5 a 7 miembros sustituido con un miembro seleccionado del grupo que consiste de hidrogeno, alquilo, y grupos arilo, en donde el compuesto ciclico puede comprender de 1 a 2 atomos de nitrogeno y de 0 a 1 atomos de oxigeno, en donde los atomos de nitrogeno no se conectan directamente uno con otro o con el atomo de oxigeno.
MX2007005172A 2004-10-28 2005-10-26 Terapia adjunta para la depresion. MX2007005172A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62304404P 2004-10-28 2004-10-28
PCT/US2005/038804 WO2006050037A1 (en) 2004-10-28 2005-10-26 Adjunctive therapy for depression

Publications (1)

Publication Number Publication Date
MX2007005172A true MX2007005172A (es) 2007-06-22

Family

ID=35966035

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005172A MX2007005172A (es) 2004-10-28 2005-10-26 Terapia adjunta para la depresion.

Country Status (12)

Country Link
US (1) US8729120B2 (es)
EP (1) EP1819328A1 (es)
JP (1) JP2008518921A (es)
KR (1) KR20070083826A (es)
CN (1) CN101132787A (es)
AU (1) AU2005302589B2 (es)
BR (1) BRPI0518233A2 (es)
CA (1) CA2587481A1 (es)
IL (1) IL182746A (es)
MX (1) MX2007005172A (es)
RU (1) RU2007119648A (es)
WO (1) WO2006050037A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1890684B1 (en) 2005-06-08 2013-08-14 SK Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
EP1893291B1 (en) * 2005-06-22 2010-03-03 SK Holdings Co., Ltd. Treatment of sexual dysfunction
WO2008055022A2 (en) * 2006-10-30 2008-05-08 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
KR102173587B1 (ko) 2009-06-22 2020-11-04 에스케이바이오팜 주식회사 피로의 치료 또는 예방 방법
US8895609B2 (en) 2009-11-06 2014-11-25 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
KR101783633B1 (ko) * 2009-11-06 2017-10-10 에스케이바이오팜 주식회사 섬유근육통 증후군의 치료 방법
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
SG11201507121RA (en) 2013-03-13 2015-10-29 Aerial Biopharma Llc Treatment of cataplexy
CN110638805A (zh) * 2013-07-12 2020-01-03 爵士制药国际Iii有限公司 促进吸烟停止
PT3021838T (pt) 2013-07-18 2020-09-01 Sk Biopharmaceuticals Co Ltd Tratamento para a obesidade
TWI655179B (zh) 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
JP6466792B2 (ja) * 2015-07-03 2019-02-06 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥／多動性障害（ａｄｈｄ）の治療方法
EP4364794A3 (en) 2016-09-06 2024-07-24 Axsome Malta Ltd. Solvate form of (r)-2-amino-3-phenylpropyl carbamate
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
MY202185A (en) 2016-10-06 2024-04-15 Jazz Pharmaceuticals Ireland Ltd Carbamoyl phenylalaninol compounds and uses therof
AU2018278332B2 (en) 2017-06-02 2022-05-19 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
US11413264B2 (en) 2017-07-31 2022-08-16 Jazz Pharmaceuticals Ireland Limited Carbamoyl phenylalaninol analogs and uses thereof
CN110655500B (zh) * 2018-06-28 2020-12-08 浙江京新药业股份有限公司 氨基甲酸酯衍生物及其制备方法和用途
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100197892B1 (ko) * 1994-09-09 1999-06-15 남창우 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법
US5756817C1 (en) * 1995-02-11 2001-04-17 Sk Corp O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same
KR0173862B1 (ko) 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
KR0173863B1 (ko) 1995-04-10 1999-04-01 조규향 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
WO2002009694A1 (en) * 2000-08-02 2002-02-07 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful for the treatment of depression
EP1723957A3 (en) 2002-12-27 2013-01-23 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
AR042806A1 (es) * 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo

Also Published As

Publication number Publication date
EP1819328A1 (en) 2007-08-22
CA2587481A1 (en) 2006-05-11
US20080039529A1 (en) 2008-02-14
RU2007119648A (ru) 2008-12-10
KR20070083826A (ko) 2007-08-24
JP2008518921A (ja) 2008-06-05
IL182746A (en) 2014-08-31
IL182746A0 (en) 2007-09-20
BRPI0518233A2 (pt) 2008-11-11
AU2005302589A1 (en) 2006-05-11
CN101132787A (zh) 2008-02-27
US8729120B2 (en) 2014-05-20
WO2006050037A1 (en) 2006-05-11
AU2005302589B2 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
MX2007005172A (es) Terapia adjunta para la depresion.
DE602005010828D1 (de) Rasierapparate und klingenuntergruppen dafür sowie herstellungsverfahren
DE602005016526D1 (de) Rasiermesser und klingenuntergruppen dafür sowie herstellungsverfahren
MY140807A (en) Shaving razors with multiple blades
PL1802428T3 (pl) Urządzenie do golenia wyposażone w oddzielne segmenty wkładu z ostrzami
WO2010037079A3 (en) Razors and razor cartridges with a decreased total interblade span
ZA200907325B (en) Razor
MX2007004836A (es) Hojas de afeitar y cartuchos.
MX2010004764A (es) Preforma del ensamble de hojas de la rasuradora.
PL1729936T3 (pl) Wkład nożyków do golenia
RU2008134922A (ru) Бритвы
MX2018006703A (es) Navajas de afeitar y cartuchos de afeitar.
ATE493239T1 (de) Schneidglieder für nassrasierer mit mehreren klingen
EP2168729A4 (en) INNER BLADES OF AN OSCILLATING ELECTRIC SHAVER
MX2010003350A (es) Tramos decrecientes entre cuchillas.
WO2010068136A8 (ru) Лезвийный блок безопасной бритвы
DE602006021010D1 (de) Rasiergerät mit beweglicher klinge
ATE367898T1 (de) Manueller sicherheits-gemüseschneider
WO2016036238A3 (en) Spacer for a shaving system for wet shaving, as well as razor provided with the spacer
WO2007064699A3 (en) Razor blade and method of making it
ATE374677T1 (de) Scherkopf für ein haarschneidegerät
ATE501819T1 (de) Rasierapparat
DE60302433D1 (de) Schutzleiste für eine rasierklingeneinheit
WO2012033362A3 (ko) 초벌 면도와 마무리 면도 겸용 양면면도기
ATE491553T1 (de) Elektrisches haarschneidegerät

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: SCIENTIFIC GAMES HOLDINGS LIMITED

GB Transfer or rights

Owner name: SK BIOPHARMACEUTICALS CO., LTD.*

FG Grant or registration